AstraZeneca buoyed as Imfinzi cuts lung cancer deaths by a third
By Ben Hirschler LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi cut the...
Read More
Updated
Roche’s Tecentriq, trailing rival drugs, lifts lung cancer survival
By John Miller ZURICH (Reuters) – A drug cocktail with Roche’s Tecentriq added two...
Read More
FDA is considering banning online sales of e-cigarettes: Gottlieb
Washington D.C. (Reuters) – U.S. regulators are considering banning the online sales of...
Read More
High-nicotine e-cigarettes flood market despite FDA rule
By Chris Kirkham (Reuters) – The sleek Juul electronic cigarettes have become a phenomenon...
Read More
Brazil court strips Gilead of hepatitis C drug patent
By Maria Carolina Marcello and Gram Slattery BRASILIA/SAO PAULO (Reuters) – A Brazilian...
Read MoreKids may pick up marijuana at younger age if mom uses
By Linda Carroll (Reuters Health) – When mom uses marijuana, kids are more likely to try the drug at a younger age, a new study shows. When mothers used cannabis during the first 12 years of a child’s life, there was...
Read MoreEndo puts Vasostrict case against U.S. FDA on hold
(Reuters) – Endo International Plc is halting its lawsuit against the U.S. Food And Drug Administration until the end of the year after the agency made new commitments on the regulation relating to the active ingredient in...
Read More
AstraZeneca diabetes drug cuts heart risks in major study
By Ben Hirschler LONDON (Reuters) – AstraZeneca’s diabetes drug Farxiga met a key goal...
Read MoreChina says new African swine fever outbreak reported in Inner Mongolia
BEIJING (Reuters) – China said on Monday it has confirmed a new outbreak of African swine fever in the Inner Mongolia Autonomous Region of northern China, as authorities struggle to contain the highly contagious disease....
Read More
As China builds biotech sector, cash floods U.S. startups
By Robin Respaut and Julie Zhu SAN FRANCISCO/HONG KONG (Reuters) – For three whirlwind days...
Read More
With new blood test, Roche dives deeper into personal cancer care
ZURICH (Reuters) – Swiss drugmaker Roche upped its bet on personalized cancer treatment on...
Read More
U.S. agency accuses Walmart of pregnancy discrimination in lawsuit
By Daniel Wiessner (Reuters) – The U.S. Equal Employment Opportunity Commission on Friday...
Read More
Congo confirms Ebola case at Ugandan border
GOMA, Democratic Republic of Congo (Reuters) – Democratic Republic of Congo has confirmed a...
Read More
China reports first case of African swine fever Jilin province
BEIJING (Reuters) – China reported two new cases of African swine fever on Friday, as the...
Read More
Technogym targets content fix for fitness fans to sustain growth
By Giulia Segreti MILAN (Reuters) – Italy’s Technogym is looking to offer fitness...
Read MoreEU approves fifth copy of AbbVie’s $18 billion drug Humira
By Ben Hirschler LONDON (Reuters) – Europe has approved a fifth copy of AbbVie’s $18-billion-a-year biologic drug Humira – the world’s best-selling prescription medicine – ramping up competition among makers of...
Read More
Bayer’s Monsanto asks U.S. court to toss $289 million glyphosate verdict
By Tina Bellon (Reuters) – Bayer AG unit Monsanto on Tuesday asked a California judge to...
Read MoreUK rejects adult Novartis CAR-T therapy, after ‘yes’ in kids
LONDON (Reuters) – Health authorities in England have rejected a pricey CAR-T cell therapy from Novartis for adults with blood cancer, two weeks after endorsing its use in children and young people. The National Institute...
Read More
AstraZeneca plots China robot offensive to counter price cuts
By Adam Jourdan and Ben Hirschler WUXI, China/LONDON (Reuters) – With smart cancer...
Read More
South Africa’s highest court gives green light to private use of cannabis
JOHANNESBURG (Reuters) – South Africa’s highest court on Tuesday allowed the private...
Read More